Literature DB >> 13950624

Parkinsonism occurring with methyldopa treatment.

B M GRODEN.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS; PARALYSIS AGITANS

Mesh：

Substances：

Year:  1963        PMID： 13950624      PMCID： PMC2122870          DOI： 10.1136/bmj.1.5336.1001

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  13 in total

1.  A survey of drug-induced extrapyramidal reactions.

Authors:  F J AYD
Journal:  JAMA       Date:  1961-03-25       Impact factor: 56.272

2.  Methyldopa in hypertension. Clinical and pharmacological studies.

Authors:  C T DOLLERY; M HARINGTON
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

3.  Another hypotensive agent--methyldopa.

Authors:  D DALEY; B EVANS
Journal:  Br Med J       Date:  1962-07-21

4.  Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine.

Authors:  L GILLESPIE
Journal:  Ann N Y Acad Sci       Date:  1960-10-11       Impact factor: 5.691

5.  Pharmacology of hypotensive drugs.

Authors:  M HARINGTON
Journal:  Br Med J       Date:  1960-03-05

6.  Biochemical and electroencephalographic changes in the brain of rabbits injected with 5-hydroxytryptophan (influence of chlorpromazine premedication).

Authors:  E COSTA; F RINALDI
Journal:  Am J Physiol       Date:  1958-07

7.  Serotonin as a mediator of reserpine action in brain.

Authors:  A PLETSCHER; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1956-01       Impact factor: 4.030

8.  Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.

Authors:  T L SOURKES
Journal:  Arch Biochem Biophys       Date:  1954-08       Impact factor: 4.013

9.  Tranquillizers.

Authors:  M Weatherall
Journal:  Br Med J       Date:  1962-05-05

10.  Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

Authors:  J A OATES; L GILLESPIE; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1960-06-24       Impact factor: 47.728
View more
  10 in total

1.  PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.

Authors:  M J PEASTON
Journal:  Br Med J       Date:  1964-07-18

2.  METHYLDOPA AND PARKINSONISM.

Authors:  L F PRESCOTT
Journal:  Br Med J       Date:  1964-09-12

3.  [THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].

Authors:  W UMBACH; D BAUMANN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-06-01

4.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

5.  Treatment of hypertension with methyldopa.

Authors:  P Johnson; A H Kitchin; C P Lowther; R W Turner
Journal:  Br Med J       Date:  1966-01-15

Review 6.  Diagnosis and treatment of Parkinson's disease in the elderly.

Authors:  J I Sage; M H Mark
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

7.  Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-23

8.  Parkinsonism occurring during methyldopa therapy.

Authors:  R R Strang
Journal:  Can Med Assoc J       Date:  1966-10-29       Impact factor: 8.262

9.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

10.  Interaction between levodopa and methyldopa.

Authors:  F B Gibberd; E Small
Journal:  Br Med J       Date:  1973-04-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.